AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
FECAL OCCULT BLOOD SCREENING IN THE MINNESOTA STUDY
Authors: LAUNOY G DUFFY SW PREVOST TC BOUVIER V
Citation: G. Launoy et al., FECAL OCCULT BLOOD SCREENING IN THE MINNESOTA STUDY, Journal of the National Cancer Institute, 90(6), 1998, pp. 465-467
TEST SENSITIVITY AND PROGRAM SENSITIVITY FOR CANCER SCREENING
Authors: LAUNOY G DUFFY SW PREVOST TC BOUVIER V
Citation: G. Launoy et al., TEST SENSITIVITY AND PROGRAM SENSITIVITY FOR CANCER SCREENING, Revue d'epidemiologie et de sante publique, 46(5), 1998, pp. 420-426
LUNG-CANCER AMONG CHINESE FEMALES IN SINGAPORE 1968-1992 - TIME TRENDS, DIALECT GROUP-DIFFERENCES AND IMPLICATIONS FOR ETIOLOGY
Authors: SEOW A DUFFY SW NG TP MCGEE MA LEE HP
Citation: A. Seow et al., LUNG-CANCER AMONG CHINESE FEMALES IN SINGAPORE 1968-1992 - TIME TRENDS, DIALECT GROUP-DIFFERENCES AND IMPLICATIONS FOR ETIOLOGY, International journal of epidemiology, 27(2), 1998, pp. 167-172
EVALUATION BY MARKOV-CHAIN MODELS OF A NONRANDOMIZED BREAST-CANCER SCREENING-PROGRAM IN WOMEN AGED UNDER 50 YEARS IN SWEDEN
Authors: CHEN HH THURFJELL E DUFFY SW TABAR L
Citation: Hh. Chen et al., EVALUATION BY MARKOV-CHAIN MODELS OF A NONRANDOMIZED BREAST-CANCER SCREENING-PROGRAM IN WOMEN AGED UNDER 50 YEARS IN SWEDEN, Journal of epidemiology and community health, 52(5), 1998, pp. 329-335
EFFICACY OF BREAST-CANCER SCREENING FOR FEMALE RELATIVES OF BREAST-CANCER-INDEX CASES - TAIWAN MULTICENTER CANCER SCREENING (TAMCAS)
Authors: LAI MS YEN MF KUO HS KOONG SL CHEN THS DUFFY SW
Citation: Ms. Lai et al., EFFICACY OF BREAST-CANCER SCREENING FOR FEMALE RELATIVES OF BREAST-CANCER-INDEX CASES - TAIWAN MULTICENTER CANCER SCREENING (TAMCAS), International journal of cancer, 78(1), 1998, pp. 21-26
THE GOTHENBURG BREAST SCREENING TRIAL - FIRST RESULTS ON MORTALITY, INCIDENCE, AND MODE OF DETECTION FOR WOMEN AGES 39-49 YEARS AT RANDOMIZATION - AUTHOR REPLY
Authors: BJURSTAM N BJORNELD L DUFFY SW PREVOST TC
Citation: N. Bjurstam et al., THE GOTHENBURG BREAST SCREENING TRIAL - FIRST RESULTS ON MORTALITY, INCIDENCE, AND MODE OF DETECTION FOR WOMEN AGES 39-49 YEARS AT RANDOMIZATION - AUTHOR REPLY, Cancer, 83(1), 1998, pp. 188-190
ESTIMATING SENSITIVITY AND SOJOURN TIME IN SCREENING FOR COLORECTAL-CANCER - A COMPARISON OF STATISTICAL APPROACHES
Authors: PREVOST TC LAUNOY G DUFFY SW CHEN HH
Citation: Tc. Prevost et al., ESTIMATING SENSITIVITY AND SOJOURN TIME IN SCREENING FOR COLORECTAL-CANCER - A COMPARISON OF STATISTICAL APPROACHES, American journal of epidemiology, 148(6), 1998, pp. 609-619
THE CORRECTION OF RISK ESTIMATES FOR MEASUREMENT ERROR
Authors: BASHIR SA DUFFY SW
Citation: Sa. Bashir et Sw. Duffy, THE CORRECTION OF RISK ESTIMATES FOR MEASUREMENT ERROR, Annals of epidemiology, 7(2), 1997, pp. 154-164
FACTORS RELATED TO CERVICITIS IN QASHGHAEE NOMADIC WOMEN OF SOUTHERN IRAN
Authors: KESHAVARZ H DUFFY SW SOTODEHMARAM E SARAF Z SADEGHIHASSANABADI A ZIGHAMI B TABEI Z
Citation: H. Keshavarz et al., FACTORS RELATED TO CERVICITIS IN QASHGHAEE NOMADIC WOMEN OF SOUTHERN IRAN, Revue d'epidemiologie et de sante publique, 45(4), 1997, pp. 279-285
REPEAT MEASUREMENT OF CASE-CONTROL DATA - CORRECTIONS FOR MEASUREMENTERROR IN A STUDY OF ISCHEMIC STROKE AND HEMOSTATIC FACTORS
Authors: BASHIR SA DUFFY SW QIZILBASH N
Citation: Sa. Bashir et al., REPEAT MEASUREMENT OF CASE-CONTROL DATA - CORRECTIONS FOR MEASUREMENTERROR IN A STUDY OF ISCHEMIC STROKE AND HEMOSTATIC FACTORS, International journal of epidemiology, 26(1), 1997, pp. 64-70
BREAST-CANCER AND HORMONE REPLACEMENT THERAPY - COLLABORATIVE REANALYSIS OF DATA FROM 51 EPIDEMIOLOGIC STUDIES OF 52,705 WOMEN WITH BREAST-CANCER AND 108,411 WOMEN WITHOUT BREAST-CANCER
Authors: BERAL V BULL D DOLL R KEY T PETO R REEVES G CALLE EE HEATH CW COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN L STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M ADAMI HO BERGKVIST R PERSSON I PAUL C SKEGG DCG SPEARS GFS BOYLE P EVSTIFEEVA T DALING JR HUTCHINSON WB MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BRAMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R FINE SRP CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABAL N CUADROS A BACHELOR A LE MG DEACON J PETO J TAYLOR CN MODAN B RON E FRIEDMAN GD HIATT RA LEVI F BISHOP T KOSMELJ K PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY MCPHERSON K HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AO WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARUBINI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L NEIL A VESSEY M YEATES D CROSSLEY B HERMON C JONES S LEWIS C COLLINS R MABUCHI K PRESTON D HANNAFORD P KAY C ROSEROBIXBY L YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H KATSOUYANNI K TRICHOPOULOU A DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE FOLSOM AR CHILVERS CED BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC LONGNECKER MP NEWCOMB P BERGKVIST L FARLEY TMN HOLCK S MEIRIK O
Citation: V. Beral et al., BREAST-CANCER AND HORMONE REPLACEMENT THERAPY - COLLABORATIVE REANALYSIS OF DATA FROM 51 EPIDEMIOLOGIC STUDIES OF 52,705 WOMEN WITH BREAST-CANCER AND 108,411 WOMEN WITHOUT BREAST-CANCER, Lancet, 350(9084), 1997, pp. 1047-1059
COLORECTAL-CANCER MASS-SCREENING - ESTIMATION OF FECAL OCCULT BLOOD-TEST SENSITIVITY, TAKING INTO ACCOUNT CANCER MEAN SOJOURN TIME
Authors: LAUNOY G SMITH TC DUFFY SW BOUVIER V
Citation: G. Launoy et al., COLORECTAL-CANCER MASS-SCREENING - ESTIMATION OF FECAL OCCULT BLOOD-TEST SENSITIVITY, TAKING INTO ACCOUNT CANCER MEAN SOJOURN TIME, International journal of cancer, 73(2), 1997, pp. 220-224
THE GOTHENBURG BREAST SCREENING TRIAL - FIRST RESULTS ON MORTALITY, INCIDENCE, AND MADE OF DETECTION FOR WOMEN AGES 39-49 YEARS AT RANDOMIZATION
Authors: BJURSTAM N BJORNELD L DUFFY SW SMITH TC CAHLIN E ERIKSSON O HAFSTROM LO LINGAAS H MATTSSON J PERSSON S RUDENSTAM CM SAVESODERBERGH J
Citation: N. Bjurstam et al., THE GOTHENBURG BREAST SCREENING TRIAL - FIRST RESULTS ON MORTALITY, INCIDENCE, AND MADE OF DETECTION FOR WOMEN AGES 39-49 YEARS AT RANDOMIZATION, Cancer, 80(11), 1997, pp. 2091-2099
RE - QUANTITATIVE INTERPRETATION OF AGE-SPECIFIC MORTALITY REDUCTIONSFROM THE SWEDISH BREAST CANCER-SCREENING TRIALS
Authors: TABAR L DUFFY SW CHEN HH
Citation: L. Tabar et al., RE - QUANTITATIVE INTERPRETATION OF AGE-SPECIFIC MORTALITY REDUCTIONSFROM THE SWEDISH BREAST CANCER-SCREENING TRIALS, Journal of the National Cancer Institute, 88(1), 1996, pp. 52-53
TRIAL DESIGN BASED ON SURROGATE END-POINTS - APPLICATION TO COMPARISON OF DIFFERENT BREAST SCREENING FREQUENCIES
Authors: DAY NE DUFFY SW
Citation: Ne. Day et Sw. Duffy, TRIAL DESIGN BASED ON SURROGATE END-POINTS - APPLICATION TO COMPARISON OF DIFFERENT BREAST SCREENING FREQUENCIES, Journal of the Royal Statistical Society. Series A. Statistics in society, 159, 1996, pp. 49-60
SOJOURN TIME, SENSITIVITY AND POSITIVE PREDICTIVE VALUE OF MAMMOGRAPHY SCREENING FOR BREAST-CANCER IN WOMEN AGED 40-49
Authors: DUFFY SW CHEN HH TABAR L FAGERBERG G PACI E
Citation: Sw. Duffy et al., SOJOURN TIME, SENSITIVITY AND POSITIVE PREDICTIVE VALUE OF MAMMOGRAPHY SCREENING FOR BREAST-CANCER IN WOMEN AGED 40-49, International journal of epidemiology, 25(6), 1996, pp. 1139-1145
BREAST-CANCER IN SINGAPORE - TRENDS IN INCIDENCE 1968-1992
Authors: SEOW A DUFFY SW MCGEE MA LEE J LEE HP
Citation: A. Seow et al., BREAST-CANCER IN SINGAPORE - TRENDS IN INCIDENCE 1968-1992, International journal of epidemiology, 25(1), 1996, pp. 40-45
BREAST-CANCER AND HORMONAL CONTRACEPTIVES - COLLABORATIVE REANALYSIS OF INDIVIDUAL DATA ON 53297 WOMEN WITH BREAST-CANCER AND 100239 WOMEN WITHOUT BREAST-CANCER FROM 54 EPIDEMIOLOGIC STUDIES
Authors: CALLE EE HEATH CW MIRACLEMCMAHILL HL COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN L STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M PAUL C SKEGG DCG BOYLE P EVSTIFEEVA M DALING JR MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BREMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABEL N CUADROS A BACHELOT A LE MG DEACON J PETO J TAYLOR CN ALFANDARY E MODAN B RON E FRIEDMAN GD HIATT RA BISHOP T KOSMELJ J PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G ALLEN DS BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AO WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARUBINI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L MCPHERSON K NEIL A VESSEY M YEATES D BERAL V BULL D CROSSLEY B HERMON C JONES S KEY T LEWIS C REEVES G SMITH P COLLINS R DOLL R PETO R HANNAFORD P KAY C ROSEROBIXBY L GAO YT YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE HULKA BS BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC ADAMI HO BERGSTROM R LONGNECKER MP NEWCOMB P FARLEY TMN HOLCK S MEIRIK O
Citation: Ee. Calle et al., BREAST-CANCER AND HORMONAL CONTRACEPTIVES - COLLABORATIVE REANALYSIS OF INDIVIDUAL DATA ON 53297 WOMEN WITH BREAST-CANCER AND 100239 WOMEN WITHOUT BREAST-CANCER FROM 54 EPIDEMIOLOGIC STUDIES, Lancet, 347(9017), 1996, pp. 1713-1727
BREAST-CANCER SCREENING WITH MAMMOGRAPHY IN WOMEN AGED 40-49 YEARS
Authors: TABAR L LARSSON LG ANDERSON I DUFFY SW NYSTROM L RUTQVIST LE ALEXANDER F BAINES CJ MILLER AB BJURSTAM N CHEN HH DAY NE FAGERBERG G FRISELL J IMMONENRAIHA P FRODIS E PACI E SHAPIRO S THURFJELL E WALL S BURHENNE LW
Citation: L. Tabar et al., BREAST-CANCER SCREENING WITH MAMMOGRAPHY IN WOMEN AGED 40-49 YEARS, International journal of cancer, 68(6), 1996, pp. 693-699
TUMOR-DEVELOPMENT, HISTOLOGY AND GRADE OF BREAST CANCERS - PROGNOSIS AND PROGRESSION
Authors: TABAR L FAGERBERG G CHEN HH DUFFY SW GAD A
Citation: L. Tabar et al., TUMOR-DEVELOPMENT, HISTOLOGY AND GRADE OF BREAST CANCERS - PROGNOSIS AND PROGRESSION, International journal of cancer, 66(4), 1996, pp. 413-419
BREAST-CANCER AND HORMONAL CONTRACEPTIVES - FURTHER RESULTS
Authors: CALLE EE HEATH CW MIRACLEMCMAHILL HL COATES RJ LIFF JM FRANCESCHI S TALAMINI R CHANTARAKUL N KOETSAWANG S RACHAWAT D MORABIA A SCHUMAN I STEWART W SZKLO M BAIN C SCHOFIELD F SISKIND V BAND P COLDMAN AJ GALLAGHER RP HISLOP TG YANG P DUFFY SW KOLONEL LM NOMURA AMY OBERLE MW ORY HW PETERSON HB WILSON HG WINGO PA EBELING K KUNDE D NISHAN P COLDITZ G MARTIN N PARDTHAISONG T SILPISORNKOSOL S THEETRANONT C BOOSIRI B CHUTIVONGSE S JIMAKORN P VIRUTAMASEN P WONGSRICHANALAI C MCMICHAEL AJ ROHAN T EWERTZ M PAUL C SKEGG DCG SPEARS GFS BOYLE P EVSTIFEEVA T DALING JR MALONE K NOONAN EA STANFORD JL THOMAS DB WEISS NS WHITE E ANDRIEU N BREMOND A CLAVEL F GAIRARD B LANSAC J PIANA L RENAUD R FINE SRP CUEVAS HR ONTIVEROS P PALET A SALAZAR SB ARISTIZABEL N CUADROS A BACHELOT A LE MG DEACON J PETO J TAYLOR CN ALFANDARY E MODAN B RON E FRIEDMAN GD HIATT RA BISHOP T KOSMELJ K PRIMICZAKELJ M RAVNIHAR B STARE J BEESON WL FRASER G ALLEN DS BULBROOK RD CUZICK J FENTIMAN IS HAYWARD JL WANG DY HANSON RL LESKE MC MAHONEY MC NASCA PC VARMA AP WEINSTEIN AL MOLLER TR OLSSON H RANSTAM J GOLDBOHM RA VANDENBRANDT PA APELO RA BAENS J DELACRUZ JR JAVIER B LACAYA LB NGELANGEL CA LAVECCHIA C NEGRI E MARBUNI E FERRARONI M GERBER M RICHARDSON S SEGALA C GATEI D KENYA P KUNGU A MATI JG BRINTON LA HOOVER R SCHAIRER C SPIRTAS R LEE HP ROOKUS MA VANLEEUWEN FE SCHOENBERG JA GAMMON MD CLARKE EA JONES L MCPHERSON K NEIL A VESSEY M YEATES D BERAL V BULL D CROSSLEY B HERMON C JONES S KEY T LEWIS C REEVES G SMITH P COLLINS R DOLL R PETO R HANNAFORD P KAY C ROSEROBIXBY L YUAN JM WEI HY YUN T ZHIHENG C BERRY G BOOTH JC JELIHOVSKY T MACLENNAN R SHEARMAN R WANG QS BAINES CJ MILLER AB WALL C LUND E STALSBERG H DABANCENS A MARTINEZ L MOLINA R SALAS O ALEXANDER FE HULKA BS CHILVERS CED BERNSTEIN L HAILE RW PAGANINIHILL A PIKE MC ROSS RK URSIN G YU MC ADAMI HO BERGSTROM R LONGNECKER MP NEWCOMB P FARLEY TMN HOLCK S MEIRIK O
Citation: Ee. Calle et al., BREAST-CANCER AND HORMONAL CONTRACEPTIVES - FURTHER RESULTS, Contraception, 54(3), 1996, pp. 1-106
THE VALUE OF THE 2ND VIEW IN SCREENING MAMMOGRAPHY
Authors: WARREN RML DUFFY SW BASHIR S
Citation: Rml. Warren et al., THE VALUE OF THE 2ND VIEW IN SCREENING MAMMOGRAPHY, British journal of radiology, 69(818), 1996, pp. 105-108
STOPPING DRINKING AND RISK OF ESOPHAGEAL CANCER
Authors: CHENG KK DUFFY SW DAY NE LAM TH CHUNG SF BADRINATH P
Citation: Kk. Cheng et al., STOPPING DRINKING AND RISK OF ESOPHAGEAL CANCER, BMJ. British medical journal, 310(6987), 1995, pp. 1094-1097
SURROGATE MARKERS IN AIDS AND CANCER TRIALS
Authors: DAY NE DUFFY SW TABAR L
Citation: Ne. Day et al., SURROGATE MARKERS IN AIDS AND CANCER TRIALS, Statistics in medicine, 14(23), 1995, pp. 2619-2620
ESTIMATION OF MEAN SOJOURN TIME IN BREAST-CANCER SCREENING USING A MARKOV-CHAIN MODEL OF BOTH ENTRY TO AND EXIT FROM THE PRECLINICAL DETECTABLE PHASE
Authors: DUFFY SW CHEN HH TABAR L DAY NE
Citation: Sw. Duffy et al., ESTIMATION OF MEAN SOJOURN TIME IN BREAST-CANCER SCREENING USING A MARKOV-CHAIN MODEL OF BOTH ENTRY TO AND EXIT FROM THE PRECLINICAL DETECTABLE PHASE, Statistics in medicine, 14(14), 1995, pp. 1531-1543
Risultati: 1-25 | 26-43